XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
$ in Thousands, € in Millions, ৳ in Millions, ¥ in Millions, £ in Millions, $ in Millions, $ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
Jan. 01, 2023
USD ($)
$ / shares
Profit or loss [abstract]    
Net sales (note 27) $ 3,195,911 $ 3,240,482
Cost of sales (note 17(c)) 2,315,857 2,248,070
Gross profit 880,054 992,412
Selling, general and administrative expenses (note 17(a)) 330,391 326,258
Gains (losses) arising from sale and leaseback transactions (25,010) 0
Net insurance gains (note 17(f)) (74,172) 0
Restructuring and acquisition-related costs (note 18) 45,762 479
Impairment reversal (40,770) 62,290
Operating income 643,853 603,385
Financial expenses, net (note 15(c)) 79,670 36,957
Earnings before income taxes 564,183 566,428
Income tax expense (note 19) 30,603 24,888
Net earnings 533,580 541,540
Other comprehensive (loss) income, net of related income taxes:    
Cash flow hedges (note 15(d)) 3,805 (54,964)
Actuarial gain on employee benefit obligations (note 13(a)) 1,717 8,094
Other comprehensive income 5,522 (46,870)
Comprehensive income $ 539,102 $ 494,670
Earnings per share (note 20):    
Basic (in dollars per share) | $ / shares $ 3.03 $ 2.94
Diluted (in dollars per share) | $ / shares $ 3.03 $ 2.93